Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors

Clinical trial NCT04299191 · RECRUITING

Trial details

NCT number: NCT04299191
Sponsor: Laminar Pharmaceuticals
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

High-grade Glioma Solid Tumor, Unspecified, Child

Start date: 2020-09-01
Primary completion: 2026-10-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.